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Abstracts / Osteoarthritis and Cartilage 22 (2014) S7–S56 S19synovial lining and ﬁbrous and inﬂammatory processes, were noticed in
OA group. Hyaluronan scaffold displayed only a minor role in favoring
the wound-healing processes in the cartilage, synovial membrane and
menisci. There were instead a general beneﬁcial effect on these tissues,
when this scaffold was implanted with BMC and/or MSC. Macroscopic,
histological and immunohistochemical assessments clearly showed in
detail in BMC group an enhancement of cartilage repair in terms of a
down-regulation of some ﬁbrous, catabolic, hypertrophic and inﬂam-
matory markers particularly in medial femoral condyle respect OA
group (P<0.05). Moreover, the use of BMC determined an improvement
of various histological aspects in synovial membrane and menisci
reducing the ﬁbrous and inﬂammatory states respect OA group. MSC
group displayed a positive contribution particularly on medial femoral
condyle and low effect in tibial plateau due to the biomechanics of the
articular joint in sheep.
Conclusions: The sheep was chosen for this work because of its sim-
ilarities with humans, which render it an useful model. The ﬁndings
obtained in this study would support the use of BMC in clinical practice
for OAmanagement, as useful therapeutic tool, leading to a reduction of
the degenerative and inﬂammatory processes in cartilage, synovial
membrane and menisci during OA setting. Moreover, the clinical
application of BMC in OA management is attractive because it would
allow a one- step procedure, avoiding all the complications related to in
vitro cell manipulation, thus complying with US Food and Drug Asso-
ciation (FDA) restrictions.
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Purpose: Systemic application of the 1-34 amino acid segment of the
parathyroid hormone (PTH [1-34]) stimulates bone formation, enhan-
ces diaphyseal fracture healing, and is approved for the clinical treat-
ment of postmenopausal osteoporosis. However, the effect of PTH [1-
34] on the subchondral bone is poorly understood. Here, we tested the
hypothesis that subcutaneous application of PTH [1-34] over 6 weeks
induces changes in the microarchitecture of the subchondral bone that
reciprocally affect the integrity of the articular cartilage within a naïve
osteochondral unit in vivo.
Methods: Daily subcutaneous injections of 10 mg PTH [1-34] per kg
body weight were given to the treatment group (n ¼ 4 adult female
Chinchilla bastard rabbits) for 6 weeks, controls received saline. The
animals were allowed full weight bearing and were fed a standard diet.
Blood samples were continuously collected to monitor renal function.
After sacriﬁce, the subchondral bone plate and subarticular spongiosa of
the femoral heads (n ¼ 16) were separately assessed by micro-com-
puted tomography. Osteoarthritic changes of the articular cartilage
were evaluated by macroscopic assessment and histological grading of
safranin orange/fast green stained sections, by polarized light micro-
scopy, and by computerized assessment of the mean immunostaining
intensities for type-I, type-II, and type-X collagen (Acris, Hiddenhausen,
Germany). Absolute and relative extents of hyaline and calciﬁed artic-
ular cartilage layers were determined histomorphometrically in a
standardized fashion on Goldner’s trichrome stained sections. The
effect of PTH [1-34] on apoptosis and PTH receptor (PTH1R) expression
of osteocytes and chondrocytes was determined by immunostaining,
applying a polyclonal caspase-3 (Cell Signaling Technology, Frankfurt,
Germany) and a monoclonal mouse PTH1R antibody (Abcam, Cam-
bridge, UK), respectively. Statistical comparison was conducted using a
linear model with generalized estimating equations. The Pearson cor-
relation coefﬁcient was applied to determine the strength of association
between PTH-induced key changes in subchondral bone and articular
cartilage. Data are given as mean  standard deviation. Two-tailed
values of p < 0.05 were considered signiﬁcant.
Results: PTH [1-34] enhanced bone volume (BV/TV; 45.58 3.69 versus
40.12  3.35%; p ¼ 0.010), mineral density (BMD; 1,062.48  104.16
versus 931.59  60.94 mg calcium hydroxyapatite/cm3; p ¼ 0.017), and
trabecular thickness (Tb.Th; 0.14  0.01 versus 0.13  0.01 mm; p ¼0.042) within the subarticular spongiosa, without affecting the sub-
chondral bone plate. Besides, PTH [1-34] signiﬁcantly increased the
thickness of the calciﬁed cartilage layer (285.32  46.17 versus 163.45
31.30 mm; p¼ 0.001). Moreover, PTH [1-34] also increased degeneration
of the articular cartilage (4.28 1.47 versus 1.97  0.46 overall score
points; p ¼ 0.040), reﬂected by cartilage surface irregularities (1.11 
0.96 versus 0.25  0.59; p < 0.001) and reduced matrix staining (2.75 
1.65 versus 1.68  0.55; p ¼ 0.029). Importantly, statistical analysis
revealed that such early osteoarthritic changes of the articular cartilage
correlate with (r ¼ 0.56) and are ascribed to the increased thickness of
the calciﬁed cartilage layer (p ¼ 0.026) and the enhanced mineral
density of the subarticular spongiosa (p ¼ 0.001). Systemic admin-
istration of PTH [1-34] neither affected the rate of apoptotic osteocytes
and chondrocytes within the osteochondral unit nor induced renal
failure, as serum levels of creatinine, phosphate, and urea nitrogen
remained constant over the observation period and were similar
between treatment and control group (p > 0.05 for all time points). The
macroscopic aspect of the articular cartilage, type-I, type-II, type-X
collagen content and distribution, and PTH1R expression remained
unaffected (all p > 0.05).
Conclusions: These ﬁndings identify a mechanism by which systemic
PTH [1-34] may provoke early osteoarthritis of the hyaline articular
cartilage by inducing microarchitectural modiﬁcations of the sub-
articular spongiosa and broadening of the calciﬁed cartilage layer.
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Purpose: Peripheral and central sensitization is associated with knee
pain severity in knee osteoarthritis (OA). Whether sensitization occurs
prior to or only concurrently with development of OA pain is not known
as prior studies have only been cross-sectional. Such insights would
have implications for understanding whether sensitization may be an
inherent trait vs. an induced state. We report here the ﬁrst longitudinal
evaluation of the effect of sensitization and its change over two years to
the incidence of knee pain and clinically meaningful change in pain
severity.
Methods: The Multicenter Osteoarthritis (MOST) Study is a NIH-funded
longitudinal cohort of persons with or at risk of knee OA. Subjects had
x-rays and WOMAC pain severity obtained at each study visit, and a
standardized somatosensory evaluation of mechanical temporal sum-
mation and pressure pain thresholds (PPT) at the wrist and patella at
60- and 84-months. Temporal summation was deﬁned by increased
pain during repeated mechanical stimulation (1 Hz x 30-sec) with a 60g
monoﬁlament. PPT was assessed with an algometer (1cm2 tip, 0.5 Kg/
sec) as the point at which the subject felt the pressure change to slight
pain. The average of 3 PPT trials was categorized into sex-speciﬁc ter-
tiles. Lower PPT indicates more sensitivity. Incident consistent frequent
knee pain (CFKP, pain on most days of the past 30 days on both a tel-
ephone screen and clinic visit) at the 84-month visit was determined
from among knees that did not have CFKP at the 60-month visit. Inci-
dent symptomatic knee OA (SxOA) at the 84-mo visit was deﬁned as
radiographic knee OA (ROA, KL grade 2) plus CFKP, assessed among
knees free of pain at the 60-mo visit with or without ROA. We used the
minimal clinically important difference (MCID) in WOMAC pain to
examine sensitization effects on clinically meaningful changes in pain
severity. We examined the relation of the baseline and 2-year changes
in somatosensory tests to each of these pain outcomes using logistic
regression with GEE. All analyses were adjusted for potential con-
founders (see Table for list).
Results: A total of 2308 subjects met eligibility criteria for these anal-
yses (mean age 67.6, mean BMI 30.9, 61% female). Neither temporal
summation nor PPT were associated with incident CFKP or incident
SxOA (ORs 0.7-1.2, all p>0.05). Baseline temporal summation at the
wrist was associated with a trend towards increased risk of MCID in
WOMAC pain worsening at follow-up, but baseline PPT was not asso-
ciated (Table). However, a decrease in PPT (:sensitivity) over 2 years
